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Abstract
Background: The Autism Spectrum Quotient (AQ) is a self-report questionnaire for quantifying autistic traits. This study 
tests whether the AQ can differentiate between parents of children with an autism spectrum condition (ASC) and 
control parents. In this paper, the use of the AQ to define the broader, medium and narrow autism phenotypes (BAP, 
MAP, NAP) is reported, and the proportion of parents with each phenotype is compared between the two groups.
Methods: A sample of 571 fathers and 1429 mothers of children with an ASC completed the AQ, along with 349 
fathers and 658 mothers of developing typically children.
Results: Both mothers and fathers of the diagnosed children scored higher than the control parents on total AQ score 
and on four out of five of the subscales. Additionally, there were more parents of diagnosed children with a BAP, MAP or 
NAP.
Conclusions: The AQ provides an efficient method for quantifying where an individual lies along the dimension of 
autistic traits, and extends the notion of a broader phenotype among first-degree relatives of those with ASC. The AQ is 
likely to have many applications, including population and clinical screening, and stratification in genetic studies.
Background
Autism spectrum conditions (ASC) are diagnosed on the
basis of behaviour, specifically difficulties in social and
communication development, alongside repetitive behav-
iour and unusually narrow strong interests [1]. The evi-
dence for the genetic basis of ASC initially came from
twin studies of classic autism [2,3] and more recently twin
studies of autistic traits [4-6]. Progress from these epide-
miological findings to identifying specific DNA sequence
variations that cause ASC has been slow: replication of
results has been hampered by methodological issues such
as limited power, varying designs and genotyping, along
with imprecise phenotypic definitions [7]. Another rea-
son for limited progress is that although ASC has a high
inheritance rate, it is genetically heterogeneous. Rare de
novo  mutations and chromosomal abnormalities could
account for as many as 20% of ASC cases, but common
allelic variation is also important, suggesting that a cate-
gorical approach to case ascertainment may not always be
the best approach [8].
Indeed, a case-control or categorical approach to diag-
nosis ignores the view that autism is not just a spectrum
within the clinical population, but that autistic traits are
continuously distributed right through the general popu-
lation [5,9]. Taking seriously the dimensional view neces-
sitates the use of techniques such as quantitative trait loci
(QTL) analysis. Quantitative traits are characteristics that
can be associated with a particular condition but are also
continuously distributed in the non-affected population.
If QTL is to be a successful tool in the search for autism
susceptibility genes, then an instrument that can quantify
autism traits in both affected and non-affected individu-
als is required. As well as quantifying autism traits within
the whole population, such an instrument could also be
used to define the broader autism phenotype (BAP).
The BAP is generally considered to be a subclinical set
of characteristics or traits that index familiality and/or
genetic liability to autism. This conception holds that the
BAP is milder but qualitatively similar to the diagnosed
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autism phenotype. BAP characteristics were first
observed by Kanner [10], and were also noted in Folstein
and Rutter's early twin study [3], which found a higher
concordance rate for a more broadly defined cognitive
impairment.
Given the increasing importance of measuring the BAP,
not only in genetic studies, but across autism research
(for example, in neuroimaging and cognitive studies), it is
important to select the right tool. There are already at
least four instruments available for the assessment of the
BAP: the Family History Interview (FHI), developed by
Rutter and Folstein; the Social Responsiveness Scale
(SRS) [11]; the Broader Phenotype Autism Symptom
Scale (BPASS) [12]; and the Broad Autism Phenotype
Questionnaire (BAPQ) [13].
The FHI measures autism-related traits in family mem-
bers via interview with one member. The instrument cov-
ers social and communication skills and range of
interests. An algorithm determines the presence or
absence of the BAP in the three domains. The FHI was
used by Bolton and colleagues [14] to demonstrate higher
rates of the BAP in the parents and siblings of probands
with autism compared with probands with Down's syn-
drome. This finding was replicated by Piven and col-
leagues [15].
The SRS is a 65-item questionnaire, which is completed
by an adult informant. Its focus is on the ability of the
subject of the questionnaire to engage in emotionally
appropriate reciprocal social interaction and communi-
cation. Using the SRS, a higher number of autistic traits
h a v e  b e e n  o b s e r v e d  i n  t h e  s i b l i n g s  o f  c h i l d r e n  w i t h
autism [16].
The BPASS was developed specifically for use in QTL
studies [12]. This instrument comprises seven semistruc-
tured interview items and six observation items, which
together cover social motivation, social expressiveness,
conversational skills and repetitive/restricted behav-
iours. The BPASS is for use with both adults and children.
The most recently published instrument, the BAPQ,
comprises 36 items, 12 in each of three subscales: aloof
personality, pragmatic language deficits, and rigid per-
sonality. Ideally, scores from self- and informant reports
are combined to give a best-estimate rating. The BAPQ
has been validated using direct clinical assessment of
BAP [13].
We suggest that when choosing an instrument to mea-
sure autistic traits in both the affected and non-affected
populations, the following qualities are important. (i) A
good BAP measure should be quantitative, with a wide
range of possible scores, avoiding both ceiling and floor
effects. (ii) The content validity should be such that the
instrument can distinguish people with from those with-
out an ASC. (iii) Versions of the same instrument should
be available for use with individuals of different ages,
both adults and children. (iv) Ideally, the instrument
should produce a normal or near-normal distribution in
the general population. (v) The instrument should have
good test-retest reliability. (vi) It should have good cross-
cultural applicability. (vii) It should correlate with either
biological and/or psychological measures of the broader
phenotype (concurrent validity). Finally, (viii) it should be
quick and easy to use: participants in research projects
should be subjected to the least amount of testing possi-
ble, without compromising the validity of the research
project.
Bearing in mind these qualities, each of the four instru-
ments described above have some weaknesses: the FHI
and BPASS are not truly quantitative and are both time-
consuming to administer, the SRS is not normally distrib-
uted, and the BAPQ is currently limited to adults.
In this paper, we propose that an alternative to the four
instruments already available is the Autism Spectrum
Quotient (AQ) [9]. The AQ was developed to assess
where an individual lies on the autism spectrum (that is,
how many autistic traits that person exhibits). Originally
designed for adults, there are now child ( 4-11 years old)
[17] and adolescent (12-16 years old) [18] versions avail-
able (both completed by parents to improve accuracy).
The questionnaires are freely available to download http:/
/www.autismresearchcentre.com.
The AQ for adults has the format of a self-report,
forced-choice questionnaire and is at the reading level of
a typical 10-year-oldl. It can be used by adults with an IQ
in the average range, who can read and understand at
least to this level. There are 50 items, covering behaviours
across five domains: communication, social skills, atten-
tion switching, imagination, and attention to detail. Each
item has the format of a statement with which the
respondent rates how strongly they agree or disagree,
using a four-point scale. In fact, each item is only scored
as '1' if the person reports the autistic trait, and '0' if they
do not, so total scores on the AQ can range from 0 to 50.
Some researchers have used a four-point Likert scale for
the AQ [19-21], but this does not significantly alter the
pattern of results. The AQ is quick and easy to use and
produces a near-normal distribution in the general popu-
lation [9].
The adult AQ has been used extensively, and has been
shown to have consistent results both across time [22]
and culture [20,23]. The AQ demonstrates high heritabil-
ity [5]. The AQ score is a good predictor of clinical diag-
nosis [24], correlates with brain function [25], single
nucleotide polymorphisms (SNPs) in candidate genes
[26], social attention [27,28] and even prenatal testoster-
one levels [29].
A previous study, by Dorothy Bishop and colleagues,
suggested that AQ scores differentiate parents of children
with an ASC from control parents on two subdomains:Wheelwright et al. Molecular Autism 2010, 1:10
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communication and social skills [29]. Although this was a
pioneering study, its limitation was that it only tested 65
mothers and 46 fathers of children with a pervasive devel-
opmental disorder (PDD) diagnosis, and 48 mothers and
37 fathers of control children. Although this study indi-
cates the potential of the AQ to serve as a measure of the
BAP, it is not clear whether the lack of significance on
three of the five subdomains of the AQ is because these
play no role in the BAP or because the sample size was
too small. Therefore, in the current study, we used the
AQ with a much larger sample of parents.
Our first aim was thus to test if the results found by
Bishop and colleagues [29]could be replicated in a new,
and considerably larger, sample. The second aim was to
test the proportion of parents of children with an ASC
who demonstrate the BAP, the medium autism pheno-
type (MAP) and the narrow autism phenotype (NAP).
The MAP and NAP are new concepts. An individual with
the NAP has a large number of autistic traits, and most
(but not all) people with the NAP will also have a diagno-
sis on the autism spectrum. Not all individuals with the
NAP will be diagnosed because there are many reasons
why an individual may seek or receive a diagnosis: the
NAP is one band within the phenotypic spectrum and
does not take into consideration the individual's context,
which may mediate whether they actually need or receive
a diagnosis. Using the AQ, we define the NAP as those
scoring ≥ 3 standard deviations (SDs) above the mean. An
individual with the MAP has a medium number of autis-
tic traits (defined as individuals scoring between 2 to 3
SDs above the mean on the AQ), and an individual with
the BAP has even fewer traits, but still significantly more
than average (defined as individuals scoring 1 to 2 SDs
above the mean on the AQ). People with the MAP or
BAP are unlikely to require clinical intervention, but their
phenotypic status may be informative at a genetic level.
Methods
Instrument
Full details about the construction of the AQ are available
elsewhere [9]. The AQ consists of a series of 50 state-
ments. Participants are asked to indicate whether they
'strongly agree', 'slightly agree', 'slightly disagree' or
'strongly disagree' with each statement. Each item scores
zero or one, with one point being awarded if the partici-
pant chooses the 'autistic trait' response. On half the
items, the 'autistic trait' response is 'slightly/strongly
agree', and on half the items the 'autistic trait' response is
'slightly/strongly disagree'. A total score is calculated by
summing across items. The BAP, MAP and NAP scores
are calculated using the mean and SD from the combined
male and female control individuals shown in Table 1 (n =
1761, mean ± SD = 16.3 ± 5.9; taken from [22]) BAP is
defined as AQ scores of 1 to 2 SDs above the mean (AQ
scores of 23 to 28). MAP is defined as AQ scores of 2 to 3
SDs above the mean (AQ scores of 29 to 34). NAP is
defined as AQ scores ≥ 3 SDs above the mean (AQ scores
of 35+).
Participants and procedure
Two groups of parents took part in the study: parents of
children with a diagnosis on the autism spectrum and
parents of families who only had children who were
developing typically. The parents of children with an ASC
were recruited from families who registered on the Cam-
bridge University Autism Research Centre volunteer
database between 2002 and 2009 (online at http://
www.autismresearchcentre.com). Ethics approval for the
database and questionnaire collection was provided by
the Cambridge Psychology Research Ethics Committee.
Parents gave informed consent to take part in the study
electronically.
Parents registering on the database are asked to state
the diagnosis of their child, who made the diagnosis, and
where and when. In addition, parents are asked to pro-
vide information about the IQ and language development
of their child, although this is not obligatory. After regis-
tering, the parents are invited to complete an AQ, and are
asked to encourage the other biological parent to also
register and complete an AQ. The advantage of using an
online website to collect these data is that large samples
can be collected. The disadvantage is that diagnosis can-
not be validated in every case. All parents included in this
study reported that their children had received their diag-
nosis from experienced clinicians in recognized clinics
and according to the criteria from the Diagnostic and
Statistical Manual of Mental Disorders, 4th edition
(DSM-IV) or the International Statistical Classification
of Diseases and Related Health Problems, 10th Revision
(ICD-10).
In total, 1582 families took part, with 571 fathers and
1429 mothers completing the AQ. There were question-
naires from 418 couples. The mean age of the fathers for
whom these data were available (n = 551) was 44.0 ± 6.9
years and for mothers (n = 1228) was 41.2 ± 7.5 years.
The numbers of diagnosed and developing typically chil-
dren in the 1582 families are shown in Tables 1 and 2.
There were 1752 children with a diagnosis of ASC:1472
male and 280 female, giving a male:female ratio of 5.3:1.
of he 1752 children, 727 were reported to have autism,
725 to have Asperger's syndrome (AS), 185 to have high
functioning autism (HFA) and 115 to have pervasive
development disorder. As a further check on diagnostic
subtype, the registration process asks about comorbid
language delays or learning difficulties. A diagnosis of AS
is only registered if the parent indicates that the child did
not have any language or general developmental delay. A
diagnosis of HFA is only registered if the parent indicatesWheelwright et al. Molecular Autism 2010, 1:10
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that there was no general developmental delay even if
language was delayed.
For the control group, the AQ was sent to the parents of
1255 children (633 girls, 622 boys) who were participat-
ing in a large epidemiological study of social and commu-
nication skills in primary school-age children [30-32].
This part of the project was ethically approved by the
National Health Service Suffolk Research Ethics Commit-
tee, and written informed consent was obtained from
participating parents. Two copies of the questionnaire
and two consent forms were posted to each family: one
set for the mother and one set for the father. A post-paid
envelope was included for participants to return the
questionnaires and consent forms. This sample was origi-
nally ascertained by inviting 136 mainstream primary
schools in Cambridge City, east and south Cam-
bridgeshire, and Fenland in the UK to participate in
research (n = 92 (68%), agreed). In total, 1012 question-
naires were received from 669 families (661 from moth-
ers, 351 from fathers) with 343 pairs, a 40% response rate.
Two families were excluded because they reported a child
with a diagnosis or suspected diagnosis on the autism
spectrum. One family was excluded because they
reported a child with Down's syndrome. Questionnaires
from 666 families (558 mothers and 349 fathers) with 341
pairs were analysed. The mean age (at the time of com-
pleting the AQ) of the fathers for whom these data were
available (n = 344) was 44.6 ± 5.0 years and for mothers (n
= 644) was 42.4 ± 4.7. The children in these families were,
according to parental report, all developing typically, and
the numbers are shown in Table 3; in total, there were
1532 children in these families.
Results
The mean AQ scores and standard deviations are shown
for the two groups in Table 4, along with control data and
AS data [22] for comparison. The distribution of scores in
the two parent groups are shown in Figure 1 and Figure 2.
Analysis of variance (ANOVA), with between-subject
factors of 'group' (ASC parents versus control parents)
and 'gender' was carried out on total AQ score. There was
a significant main effect of group (F(1,3003) = 45.8, P <
0.001), with the ASC parents scoring higher than the con-
trol parents, and of gender (F(1,3003)) = 104.3, P < 0.001),
with males scoring higher than females. Although the
group × gender interaction was significant (F(1,3003) =
6.0, P < 0.05), simple effect tests indicated that the gender
difference held up in both groups separately (ASC par-
ents: F(1,3003) = 42.0, P < 0.001; control parents:
FF(1,3003) = 62.5, P < 0.001) and that the group differ-
ence also held up when each gender was tested separately
(males: F(1,3003) = 6.9, P < 0.01; females: F(1,3003)) =
65.4, P < 0.001). The effect sizes for the group, gender,
and group × gender interaction were all small: partial eta
squared (η2) values were 0.02, 0.03 and 0.002 respectively,
indicating that these factors accounted for just a small
amount of the overall variance.
Table 5 shows the means and standard deviations of the
five subdomains of the AQ in the parent groups only.
Also shown are the F values and partial η2 values gener-
ated by separate ANOVAs, with between-subject factors
of group (ASC parents versus control parents) and gen-
der, for each of the five subdomains. Inspection of the
means suggests that for each subcategory, males scored
higher than females, and the ASC parents scored higher
than the control parents. The exception to this was the
subcategory 'attention to details'; in this, there was no sex
difference and the control parents scored higher than the
ASC parents. These observations were partly confirmed
by the ANOVAs and simple effect tests. Similar to the
total AQ score, the subcategories 'attention switching'
and 'imagination' had significant main effects of group
and gender and a significant group × gender interaction.
Also similar to the total AQ score, simple effect tests indi-
cated that for both subcategories the sex difference held
up in both groups separately, and that the group differ-
ence also held up when each sex was tested separately (P
< 0.01 for all). The category 'communication and social
skills' both had significant main effects of group and gen-
der, but no interaction between them, whereas the sub-
category 'attention to detail' only had a significant main
effect of group. Again, all the effect sizes are small.
The number of parents matching each of the described
phenotypes (the BAP, MAP and NAP) was computed
Table 1: Number of children developing typically in the 1582 ASC families
Number of siblings developing typically 0 1 2 3 4 5
Number of families 1260 217 82 14 8 1
ASC = autism spectrum condition.
Table 2: Number of children with a diagnosis in the 1582 
ASC families
Number of diagnosed children 1 2 3 4
Number of families 1423 150 7 2
ASC = autism spectrum condition.Wheelwright et al. Molecular Autism 2010, 1:10
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along with the number scoring in the average range
(within 1 SD of the mean) and the low range (< 1 SD
below the mean). These data are presented in Figure 2.
Examination of Figure 3 shows that ASC fathers had
the highest percentage of scorers across the BAP, MAP
and NAP range (approximately 33%), compared with 23%
of ASC mothers, 22% of control fathers and 9% of control
mothers. The finding that a similar proportion of ASC
mothers and control fathers scored in the BAP or higher
range is consistent with the 'extreme male brain' theory of
autism [33]. More ASC mothers scored in the MAP and
NAP range than control fathers (χ2 = 8.2, degree of free-
dom (d.f.) = 1, P < 0.01). Control mothers had the lowest
proportion in the BAP, MAP and NAP ranges, and the
fewest number scoring in at least the BAP range. About
50% of the ASC parents and control mothers score in the
average range, compared with about 60% of the control
fathers. Control mothers were over-represented in the
low range compared with ASC mothers (χ2 = 11.2, d.f. = 1,
P  < 0.01). There was no difference between the two
groups in the proportion of fathers scoring in the low
range (χ2 = 1.7, d.f. = 1, P > 0.05).
Discussion
The AQ was developed almost 10 years ago as an instru-
ment to rapidly quantify autistic traits in both clinical and
non-clinical samples. Evidence for the construct validity
of the AQ and the use of a self-report instrument for
quantifying autistic traits comes from a wide variety of
autism-related studies in which AQ score correlates with
outcome [24-26,34-42]. The AQ is thus a reasonable tool
for assessing whether individuals can be classified as hav-
ing the BAP. Measuring the BAP is increasingly impor-
tant in genetic studies, and is also important in describing
participants in other types of research. Although it may
seem contradictory to be employing cut-off points on a
scale that was devised precisely to avoid categorical dis-
tinctions, other psychometric measures (such as IQ) have
long used this approach because there may be predictive
value in subgrouping by severity. We thus also introduce
the terms MAP and NAP as additional subgroup classifi-
cations, while acknowledging that the cut-off points are
purely statistically defined (by number of SDs above the
mean) rather than 'carving Nature at its joints'.
In the present sample, parents of children with ASC
scored significantly higher on the AQ than control par-
ents, both on total AQ score and on four of five of the
subcategories. This replicates and extends the earlier
finding by Bishop and colleagues [29] in a much larger
sample.
The effect sizes were all small, which is not surprising,
as we would not predict the BAP to be present in all par-
ents. Comparing the differences between parents who do
and do not show the BAP will be important in future
research. Furthermore, our sample is heterogeneous; it
includes parents of children with different diagnoses on
the autism spectrum, some of whom come from multi-
plex and some from simplex families. In addition, we
found not only are the rates of BAP higher in parents of
children with an ASC than in control parents, but the
rates of MAP and NAP are also higher, as measured by
the AQ. This was true for both mothers and fathers.
Table 3: Number of children in the 666 control families
Number of children 1 2 3 4 5 6 7
Number of families 85 351 183 41 5 0 1
Table 4: Mean total AQ scores for the parent groups
Males Females
n Mean SD n Mean SD
ASC parents 571 19.2 9.5 1429 16.4 9.5
Control parents 349 17.7 6.9 658 13.1 6.3
AS group 69 35.9 7.8 56 37.4 8.2
Control individuals 723 17.4 6.2 1038 15.5 5.6
Data from an AS group and controls, taken from [22] are also shown for reference.
AQ = Autism Spectrum Quotient; ASC = autism spectrum condition; AS = Asperger's syndrome.Wheelwright et al. Molecular Autism 2010, 1:10
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Study limitations
There are three methodological limitations with this
study. First, information about the families, including
child diagnosis, was fully reliant on parental report. Sec-
ondly, the questionnaires in the ASC and control groups
were collected in slightly different ways. The question-
naires from the ASC group were collected from parents
registering an interest in taking part in research, mostly
via an online website, although some were paper copies.
The questionnaires were collected over a period of 7
years. By contrast, the control group questionnaires were
collected by post, over a period of a few weeks. Although
we do not think a person's AQ score will be affected by
the method of questionnaire administration (because the
wording remains identical) this assumption warrants
future testing. The time difference between data collec-
tion was not ideal, because public awareness of autism
and related conditions has increased. However, it is not
clear what influence, if any, this would have on individ-
ual's response. Future studies should try to ensure that
data collection methods are identical for all participants.
Finally, a third limitation is that our control group only
comprised families with children who were developing
typically. Future studies could also include families who
have children with a different developmental disability, to
test if there are any effects on how parents report their
own characteristics after the diagnosis of a child is made.
We doubt this would have contributed to the present
results, because the AQ measures a range of domains,
including both social and non-social (attentional) charac-
teristics.
Conclusions
This study provides evidence that the AQ is a useful tool
for assessing autism phenotypes in non-clinical samples.
The novel terms 'medium autism phenotype' and 'narrow
autism phenotype' are introduced to extend the estab-
lished term 'broader autism phenotype', and precise
methods of measuring each are provided. We found that
33% of fathers of children with ASC and 23% of mothers
scored at or above the BAP cut-off point, with signifi-
cantly more parents of children with ASC showing MAP
and NAP than was seen among control parents. Whether
the broad, medium and narrow phenotypes are mirrored
by either neural, cognitive, endocrine, proteomic or
genetic differences will be of interest to test in the future.
Table 5: Mean (and standard deviation) scores on each of the AQ subcategories in the parent groups
Communication Social skills Attention switching Imagination Attention to detail
ASC fathers 3.1 (2.4) 4.0 (2.9) 4.5 (2.6) 3.2 (2.3) 4.4 (2.3)
ASC mothers 2.6 (2.4) 3.1 (2.8) 4.0 (2.5) 2.4 (2.2) 4.4 (2.3)
Control fathers 2.6 (1.9) 3.1 (2.5) 4.2 (2.2) 3.1 (2.1) 4.7 (2.1)
Control mothers 1.7 (1.6) 1.9 (2.1) 3.1 (2.0) 1.8 (1.7) 4.7 (2.2)
F value for group main effect (and partial
eta2)
55.6** 91.8** 39.4** 18.4** 11.1*
(0.02) (0.03) (0.01) (0.006) (0.004)
F value for sex main effect (and partial
eta2)
58.6** 85.9** 71.0** 156.0** 0.01
(0.02) (0.03) (0.02) (0.05) (0.00)
F value for group x sex interaction (and
partial eta2)
3.6 2.1 9.2* 6.9 * 0.01
(0.001) (0.001) (0.003) (0.002) (0.00)
F values (and partial eta2) from the ANOVAs are presented.
*P < 0.01, ** P < 0.001
AQ, Autism Spectrum Quotient; ASC, autism spectrum conditionWheelwright et al. Molecular Autism 2010, 1:10
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